Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

Journal of the National Cancer Institute - 4 Sept 2013

Saadatmand Sepideh, Tilanus-Linthorst Madeleine M A, Rutgers Emiel J T, Hoogerbrugge Nicoline, Oosterwijk Jan C, Tollenaar Rob A E M, Hooning Maartje, Loo Claudette E, Obdeijn Inge-Marie, Heijnsdijk Eveline A M, de Koning Harry J

Abstract excerpt

BACKGROUND: To reduce mortality, women with a family history of breast cancer are often screened with mammography before age 50 years. Additional magnetic resonance imaging (MRI) improves sensitivity and is cost-effective for BRCA1/2 mutation carriers. However, for women with a family history without a proven mutation, cost-effectiveness is unclear. METHODS: We evaluated data of the largest prospective MRI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mammography

Share to Mass Screening

Share to Medical History Taking

Share to Netherlands

Source

Identifiers

PMID: 23940285
DOI: 10.1093/jnci/djt203

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.PMID 23940285Read ↗

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.Semantic proximity Read ↗

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.Semantic proximity Read ↗

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.Semantic proximity Read ↗

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.Semantic proximity Read ↗

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.Semantic proximity Read ↗

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).Semantic proximity Read ↗

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC).Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.Semantic proximity Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

Screening for hereditary breast cancer.Semantic proximity Read ↗

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.